| Literature DB >> 35497247 |
Yuchan Ma1, Jiao Yang1, Tong Yang1, Yan Deng1, Mengqiao Gu1, Min Wang1, Rong Hu1, Yunhui Yang1.
Abstract
C-reactive protein (CRP) has become a recognized indicator of inflammation. CRP concentration in serum is an important indicator for monitoring early heart damage, and it is also a newly discovered coronary heart disease-associated inflammatory factor. A conductive nano-hybrid material composed of Au NPs and ionic liquid functionalized molybdenum disulfide (Au NPs/IL-MoS2) was prepared and utilized to immobilize primary CRP antibodies. Subsequently, 1,5-diaminonaphthalene (DN) was adsorbed onto graphene oxide (GO) through π-π stacking, which was used to load iridium nanoparticles (Ir NPs) as a tag to label secondary CRP antibodies. The large surface area of Au NPs/IL-MoS2 and the excellent electrocatalytic properties of Ir NPs/GO-DN toward the reduction of H2O2 resulted in a highly sensitive assay for CRP antigens. This immunosensor exhibited wide linear ranges from 0.01 to 100 ng mL-1 and a lower detection of limit of 3.3 pg mL-1 (S/N = 3). This CRP immunosensor can be applied in real serum sample analysis with satisfactory results, indicating that the immunosensor has potential applications in biomedical detection. This journal is © The Royal Society of Chemistry.Entities:
Year: 2020 PMID: 35497247 PMCID: PMC9050126 DOI: 10.1039/c9ra10386d
Source DB: PubMed Journal: RSC Adv ISSN: 2046-2069 Impact factor: 4.036
Fig. 1Flowchart of the preparation of immunosensor.
Fig. 2TEM characterizations of different materials: (A) Au NPs/MoS2; (B) Au NPs/IL-MoS2; (C) GO-DN; (D) Ir NPs/GO-DN.
Fig. 3Comparison of the catalytic effect of (a) GO-DN and (b) Ir NPs/GO-DN to the reduction of 3% H2O2.
Fig. 4Nyquist plots of impedance spectra by using different modified electrodes in 5 mM [Fe(CN)6]3−/4−. (a) Bare GCE; (b) Au NPs/IL-MoS2/chitosan/GCE; (c) anti-CRP/Au NPs/IL-MoS2/chitosan/GCE; (d) BSA/anti-CRP/Au NPs/IL-MoS2/chitosan/GCE; (e) CRP/BSA/anti-CRP/Au NPs/IL-MoS2/chitosan/GCE; (f) Ir NPs/GO-DN labled-anti-CRP/CRP/BSA/anti-CRP/Au NPs/IL-MoS2/chitosan/GCE.
Fig. 5Optimization of experimental conditions: (A) effects of pH on the response current of immunosensor; (B) effect of immobilized anti-CRP concentration on the response of immunosensor; (C) effects of incubation time of CRP on the response current of immunosensor; (D) effects of incubation time of labeled anti-CRP on the response current of immunosensor.
Fig. 6The calibration curve of the immunosensor (the embedded figure is the i–t curve response of the sensor to different concentrations of CRP, (a) blank; (b) 0.01 ng mL−1; (c) 1 ng mL−1; (d) 10 ng mL−1; (e) 40 ng mL−1; (f) 60 ng mL−1; (g) 80 ng mL−1; (h) 100 ng mL−1).
The comparison of proposed method with other methods for the detection of CRP
| Method | Linear range | Detection limit | Reference |
|---|---|---|---|
| Label-free immunoassay | 0.2–80 ng mL−1 | 0.04 ng mL−1 |
|
| Molecularly imprinted | 0.0625–1 mg mL−1 | 0.0625 mg mL−1 |
|
| Fluorescent aptasensor | 0.05–100 ng mL−1 | 0.01 ng mL−1 |
|
| Surface plasmon resonance-based immunoassay | 1.2–80 ng mL−1 | 1.2 ng mL−1 |
|
| Electrochemical immunosensor | 0.01–100 ng mL−1 | 3.3 pg mL−1 | This work |
Fig. 7The selectivity of immunosensor.
The recovery of CRP immunosensor
| Sample | Added (ng mL−1) | Found (ng mL−1) | Recovery (%) | Average recovery (%) |
|---|---|---|---|---|
| 1 | 5.00 | 4.95 | 99.0 | |
| 2 | 10.00 | 10.23 | 102.3 | 101.2 |
| 3 | 30.00 | 30.73 | 102.4 |